EUVIMEDEUVIMED entdecken
Crossref

Total Synthesis of (−)‐Cordycicadin D and 3,4‐ trans ‐Cordycicadins A and B: Entry to the 3,4‐ trans ‐Fused Cordycicadin Framework

Liam R Hunt iD, Phillip S Grant iD, Grace K Shimokura iD, Daniel P Furkert iD, Margaret A Brimble iD

Angewandte Chemie International Edition · 2025

DOI: 10.1002/anie.202419989 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Liam R Hunt und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Sciences, University of Auckland, 23 Symonds Street, Auckland, 1010, New Zealand. Hauptthemen laut MEDLINE: Polyketides. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Maurice Wilkins Centre for Molecular Biodiscovery.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cordycicadins A−D are four C 20 polyketides, all containing a γ‐lactone fused to a 10‐membered lactone. The proposed biosynthetic pathway for the cordycicadins anticipates the formation of two more natural products which are unknown. We report the total synthesis of (–)‐cordycicadin D and the two anticipated natural products 3,4‐ trans ‐cordycicadins A and B. The targets were convergently assembled, in a biomimetic fashion, via an efficient ketene trapping‐intramolecular Michael addition sequence that delivered the requisite 3,4‐ trans ‐fused framework with high diastereoselectivity, enabled by the synthesis of complex dioxenones that serve as in situ ketene precursors. Recognition of the embedded polyketide symmetry enabled the use of a divergent‐convergent synthetic strategy, based on the use of two products from an early‐stage enzymatic resolution. The synthetic routes afforded (–)‐cordycicadin D in 14 steps and 3,4‐ trans ‐cordycicadins A and B in 13 steps (longest linear sequence). This work confirms the structure of (−)‐cordycicadin D and the observed instability of the anticipated natural product 3,4‐ trans ‐cordycicadin B during purification may explain why it is yet to be isolated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PolyketidesStereoisomerismBiological ProductsLactonesMolecular Structure

Stichwörter der Autor:innen

Michael additionacylketenesbiomimetic synthesiscyclisationtotal synthesis

Substanzen

PolyketidesBiological ProductsLactones

Autor:innen und Institutionen

  • School of Chemical Sciences, University of Auckland, 23 Symonds Street, Auckland, 1010, New Zealand.
  • Maurice Wilkins Centre for Molecular Biodiscovery, 23 Symonds Street, Auckland, 1010, New Zealand.

ORCID-Profile: Liam R Hunt, Phillip S Grant, Grace K Shimokura, Daniel P Furkert, Margaret A Brimble

Förderung

  • Maurice Wilkins Centre for Molecular Biodiscovery

Zitieren

APA

Hunt, L. R., Grant, P. S., Shimokura, G. K., Furkert, D. P., & Brimble, M. A. (2025). Total Synthesis of (−)‐Cordycicadin D and 3,4‐ trans ‐Cordycicadins A and B: Entry to the 3,4‐ trans ‐Fused Cordycicadin Framework. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202419989

Vancouver

Hunt LR, Grant PS, Shimokura GK, Furkert DP, Brimble MA. Total Synthesis of (−)‐Cordycicadin D and 3,4‐ trans ‐Cordycicadins A and B: Entry to the 3,4‐ trans ‐Fused Cordycicadin Framework. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202419989

BibTeX
@article{Hunt2025,
  author = {Hunt, Liam R and Grant, Phillip S and Shimokura, Grace K and Furkert, Daniel P and Brimble, Margaret A},
  title = {Total Synthesis of (−)‐Cordycicadin D and 3,4‐ trans ‐Cordycicadins A and B: Entry to the 3,4‐ trans ‐Fused Cordycicadin Framework},
  journal = {Angewandte Chemie International Edition},
  year = {2025},
  doi = {10.1002/anie.202419989}
}
Kostenlos starten →